Overview
The Parnassus Growth Equity Fund offers a high-conviction portfolio of approximately 40 U.S. large-cap stocks selected for their potential to benefit from secular trends at attractive valuations.
Key Differentiators
- Innovation Oriented: Favors leading, innovative companies positioned to capitalize on secular trends.
- Emphasis on Quality: Invests selectively in companies with increasingly relevant products and services, durable competitive advantages, strong management teams and sustainable business practices that are likely to thrive in a healthy economy and be resilient in an economic recession.
- Asymmetric Return Potential: Aims to participate more in up markets than down markets, which may appeal to growth investors seeking to reduce downside volatility.
Risks
The Fund may invest in small and/or mid cap companies, which are generally riskier than larger companies, and the Fund's share price may be more volatile than funds that invest in larger companies. The adviser may be wrong in its assessment of a company's potential for growth, and the growth stocks the fund holds may not grow as the advisor anticipates. In addition, there are periods when investing in growth stocks falls out of favor with investors and these stocks may underperform. The Fund may invest in foreign securities which involve political, economic and currency risks, greater volatility and differences in accounting methods.
Fund Basics
Portfolio Managers
Performance
| Annualized Returns (%) | ||||||
|---|---|---|---|---|---|---|
| As of 03/31/2026 | 3 Month | 1 Year | 3 Year | 5 Year | 10 Year | Since 12/28/2022 |
| Parnassus Growth Equity Fund Institutional Shares | 3 Month-9.55 | 1 Year18.45 | 3 Year20.06 | 5 YearNA | 10 YearNA | Since 12/28/202223.59 |
| Russell 1000 Growth Index | 3 Month-9.78 | 1 Year18.81 | 3 Year21.18 | 5 Year12.75 | 10 Year16.82 | Since 12/28/202225.14 |
Performance data quoted represent past performance and are no guarantee of future returns. All performance assumes reinvestment of dividends and capital gains. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. For the most recent month-end performance, please select the monthly tab at the top of the page.
Growth of $10,000as of 05/31/2026
Last 5 fund distributions
| Distribution Type | Record Date | Ex/Payable Date | Dividend Rate | Nav Price Per Share |
|---|---|---|---|---|
| Distribution TypeShort-Term Capital Gain | Record Date12/18/2025 | Ex/Payable Date12/19/2025 | Dividend Rate$0.0416 | Nav Price Per Share$28.05 |
| Distribution TypeLong-Term Capital Gain | Record Date12/04/2025 | Ex/Payable Date12/05/2025 | Dividend Rate$2.7068 | Nav Price Per Share$28.49 |
| Distribution TypeShort-Term Capital Gain | Record Date12/19/2024 | Ex/Payable Date12/20/2024 | Dividend Rate$0.2414 | Nav Price Per Share$26.12 |
| Distribution TypeLong-Term Capital Gain | Record Date12/05/2024 | Ex/Payable Date12/06/2024 | Dividend Rate$1.0994 | Nav Price Per Share$26.95 |
| Distribution TypeIncome Dividend | Record Date12/19/2023 | Ex/Payable Date12/20/2023 | Dividend Rate$0.3840 | Nav Price Per Share$20.94 |
Commentary
1Q26 Parnassus Growth Equity Fund Quarterly Portfolio Update
Characteristics
Sector Weights as of 03/31/2026
Fund information is not intended to represent future portfolio composition. Weightings are based on percent of total net assets, are subject to change and should not be considered a recommendation to buy or sell any securities. Percentages may not total 100% due to rounding.
Top Holdingsas of 05/31/2026
Quarterly Performance Contributorsas of 03/31/2026
| Security Name | Total Return of the Holding (%) | Contribution to the Portfolio Return (%) |
|---|---|---|
| Security NameGE Vernova Inc. | Total Return of the Holding (%)33.74 | Contribution to the Portfolio Return (%)0.82 |
| Security NameApplied Materials Inc. | Total Return of the Holding (%)33.16 | Contribution to the Portfolio Return (%)0.74 |
| Security NameASML Holding NV ADR | Total Return of the Holding (%)23.60 | Contribution to the Portfolio Return (%)0.58 |
Quarterly Performance Detractorsas of 03/31/2026
| Security Name | Total Return of the Holding (%) | Contribution to the Portfolio Return (%) |
|---|---|---|
| Security NameMicrosoft Corp. | Total Return of the Holding (%)-23.28 | Contribution to the Portfolio Return (%)-2.05 |
| Security NameBoston Scientific Corp. | Total Return of the Holding (%)-34.19 | Contribution to the Portfolio Return (%)-0.76 |
| Security NameAmazon.com Inc. | Total Return of the Holding (%)-9.77 | Contribution to the Portfolio Return (%)-0.64 |
Fund Characteristics
| As of 03/31/2026 | PFPGX | Russell 1000 Growth Index |
|---|---|---|
| Average Weighted Market Cap | PFPGX$1349.3B | Russell 1000 Growth Index$1830.5B |
| P/E Ratio | PFPGX33.6x | Russell 1000 Growth Index33.0x |
| P/B Ratio | PFPGX8.6x | Russell 1000 Growth Index11.6x |
| Number of Holdings | PFPGX39 | Russell 1000 Growth Index387 |
| Turnover (2025 Annual) | PFPGX43.6% | Russell 1000 Growth IndexNA |
Literature
Related Insights
AI is a durable trend reshaping the global economy at unprecedented speed. Looking past headlines can reveal quality companies in chips, cloud, and software poised to compound value in the AI era.
Parnassus Growth Equity Portfolio Manager Shivani Vohra sees healthcare as the sector most exposed to changing regulations. She talks about how innovation is driving opportunities for active managers in holdings such as Boston Scientific and Intuitive Surgical. See what Shivani is watching in healthcare—and why.
Medical devices, biopharma and life-science tools are creating addressable markets that didn’t exist before. We examine the companies leading that charge and what it means for investors. Breakthrough therapies, devices and diagnostics are enabling physicians to treat patients who previously had no options.
AI is a durable trend reshaping the global economy at unprecedented speed. Looking past headlines can reveal quality companies in chips, cloud, and software poised to compound value in the AI era.
Parnassus Growth Equity Portfolio Manager Shivani Vohra sees healthcare as the sector most exposed to changing regulations. She talks about how innovation is driving opportunities for active managers in holdings such as Boston Scientific and Intuitive Surgical. See what Shivani is watching in healthcare—and why.
Medical devices, biopharma and life-science tools are creating addressable markets that didn’t exist before. We examine the companies leading that charge and what it means for investors. Breakthrough therapies, devices and diagnostics are enabling physicians to treat patients who previously had no options.



1Q26 Parnassus Growth Equity Fund Commentary